12/19
07:49 am
pbm
Psyence BioMed Announces Approval for Use of PsyLabs' Psilocybin Product in Phase IIb Clinical Trial [Yahoo! Finance]
High
Report
Psyence BioMed Announces Approval for Use of PsyLabs' Psilocybin Product in Phase IIb Clinical Trial [Yahoo! Finance]
12/19
07:28 am
pbm
Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial [Canadian Business Journal (Canada)]
High
Report
Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial [Canadian Business Journal (Canada)]
12/19
07:00 am
pbm
Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial
High
Report
Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial
12/9
07:00 am
pbm
Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical Sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science
Medium
Report
Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical Sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science
11/25
07:28 am
pbm
Psyence BioMed Announces Groundbreaking Psilocybin Longevity Research Program [Canadian Business Journal (Canada)]
Medium
Report
Psyence BioMed Announces Groundbreaking Psilocybin Longevity Research Program [Canadian Business Journal (Canada)]
11/25
07:00 am
pbm
Psyence BioMed Announces Groundbreaking Psilocybin Longevity Research Program
Low
Report
Psyence BioMed Announces Groundbreaking Psilocybin Longevity Research Program
11/20
07:50 am
pbm
Psyence BioMed Reaches Major Breakthrough in Pharmaceutical-Grade Ibogaine Supply for Worldwide Clinical and Therapeutic Markets [Yahoo! Finance]
High
Report
Psyence BioMed Reaches Major Breakthrough in Pharmaceutical-Grade Ibogaine Supply for Worldwide Clinical and Therapeutic Markets [Yahoo! Finance]
11/20
07:00 am
pbm
Psyence BioMed Reaches Major Breakthrough in Pharmaceutical-Grade Ibogaine Supply for Worldwide Clinical and Therapeutic Markets
High
Report
Psyence BioMed Reaches Major Breakthrough in Pharmaceutical-Grade Ibogaine Supply for Worldwide Clinical and Therapeutic Markets
11/12
07:00 am
pbm
Psyence BioMed Establishes Ibogaine Operations in Africa Through Strategic Investment in PsyLabs
Medium
Report
Psyence BioMed Establishes Ibogaine Operations in Africa Through Strategic Investment in PsyLabs
11/6
07:00 am
pbm
Psyence BioMed Doses Multiple Patients and Expands Clinical Sites in Phase IIb Study for Adjustment Disorder in Palliative Care
High
Report
Psyence BioMed Doses Multiple Patients and Expands Clinical Sites in Phase IIb Study for Adjustment Disorder in Palliative Care
11/3
07:00 am
pbm
Psyence BioMed Strengthens Strategic Partnership with PsyLabs Through USD $3,500,000 Follow-On Investment
High
Report
Psyence BioMed Strengthens Strategic Partnership with PsyLabs Through USD $3,500,000 Follow-On Investment